4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-22-017392
Chief Operating Officer sold 1,244 shares at $12.01 ($14,940)
- Chief Operating Officer acquired 74,135 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ADAMS R MARK Chief Operating Officer | 2022-03-04 | Grant or award | +74,135 | 124,968 | D: show line 1 in the form | ||
| ADAMS R MARK Chief Operating Officer | 2022-03-07 | Sale | −1,244 | $12.01 | $14,940 | 123,724 | D: show line 2 in the form |
| Open-market sales · 1,244 sh · avg $12.01 · $14,940 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ADAMS R MARK Chief Operating Officer | 2022-03-04 | Grant or award · Stock Option (Right to Buy) | +185,338 | 185,338 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…